The impact of drug error reduction software on preventing harmful adverse drug events in England: a retrospective database study.

Adam B SutherlandWilliam S GerrardArif PatelMichelle RandallEmma Weston

Published in: BMJ open quality (2022)

Compliance with DERS in this study was 45%. DERS events are common, but potential harm is rare. DERS events are not related to specific clinical areas. There are some issues with definition and design of drug profiles that may cause DERS events, thus future work should focus on implementation and data standardisation for future large-scale analysis.

Keyphrases

adverse drug
electronic health record
healthcare
primary care
emergency department
drug induced
risk assessment
climate change
deep learning